Literature DB >> 11410128

Nerve origin of the acoustic neuroma.

A Komatsuzaki1, A Tsunoda.   

Abstract

Two hundred and seventy-one Japanese patients who underwent surgical removal of neuroma from the cerebello-pontine angle using the translabyrinthine approach were retrospectively reviewed in order to investigate the nerve origin on an anatomical basis. In 269 out of the 271 cases, the origin of the neuromas was identified. Among these cases, 84.8 per cent of tumours originated from the inferior vestibular nerve (IVN), followed by the superior vestibular nerve (SVN) (8.9 per cent). Of the 5.6 per cent of tumours arising from the vestibular nerve, however, it could not be determined whether they originated from the SVN or IVN. Two cases of neuromas originating from the facial nerve were seen (0.7 per cent). No neuroma arose from the cochlear nerve. Currently, the diagnosis of acoustic neuromas is best made with Gd-enhanced magnetic resonance imaging (MRI). However, our data indicate that the development of a functional test of the individual IVN can be useful for screening most cases of acoustic neuroma and in facilitating their early diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11410128     DOI: 10.1258/0022215011907910

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  15 in total

Review 1.  The 100 most-cited articles on vestibular schwannoma: historical perspectives, current limitations, and future research directions.

Authors:  Rafael Martinez-Perez; Timothy H Ung; A Samy Youssef
Journal:  Neurosurg Rev       Date:  2021-02-01       Impact factor: 3.042

2.  Role of magnetic resonance imaging in evaluation of cerebellopontine angle schwannomas.

Authors:  Kunwarpal Singh; Mohit Preet Singh; Cl Thukral; Kiran Rao; Kulvinder Singh; Amandeep Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-06-24

3.  [Preoperative determination of nerve of origin in patients with vestibular schwannoma. German version].

Authors:  T Rahne; S Plößl; S K Plontke; C Strauss
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

4.  Focal T2 hyperintensity in the dorsal brain stem in patients with vestibular schwannoma.

Authors:  K Okamoto; T Furusawa; K Ishikawa; K Sasai; S Tokiguchi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

5.  What is the site of origin of cochleovestibular schwannomas?

Authors:  Christof Roosli; Fred H Linthicum; Sebahattin Cureoglu; Saumil N Merchant
Journal:  Audiol Neurootol       Date:  2011-09-29       Impact factor: 1.854

6.  Preoperative vestibular evoked myogenic potentials (VEMPs), caloric test, and pure tone audiometry to identify the vestibular nerve branch of schwannoma origin: preliminary results in a series of 26 cases.

Authors:  Francesca Cianfrone; Italo Cantore; Raffaelino Roperto; Francesco Tauro; Francesco Bianco; Luciano Mastronardi; Paolo Ruscito
Journal:  Neurosurg Rev       Date:  2022-07-12       Impact factor: 2.800

7.  Double localization of a unilateral sporadic vestibular schwannoma.

Authors:  M Barbara; F Ronchetti; V Manni; S Monini
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-02       Impact factor: 2.124

8.  Preoperative determination of nerve of origin in patients with vestibular schwannoma.

Authors:  T Rahne; S Plößl; S K Plontke; C Strauss
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

9.  [Typical tumors of the petrous bone].

Authors:  F Ahlhelm; U Müller; S Ulmer
Journal:  Radiologe       Date:  2014-04       Impact factor: 0.635

10.  Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.

Authors:  Stavros M Stivaros; Anat O Stemmer-Rachamimov; Robert Alston; Scott R Plotkin; Joseph B Nadol; Alicia Quesnel; Jennifer O'Malley; Gillian A Whitfield; Martin G McCabe; Simon R Freeman; Simon K Lloyd; Neville B Wright; John-Paul Kilday; Ian D Kamaly-Asl; Samantha J Mills; Scott A Rutherford; Andrew T King; D Gareth Evans
Journal:  J Med Genet       Date:  2015-06-23       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.